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Background: Diabetes mellitus is a chronic metabolic disease, the prevalence of which has 
registered a considerable increase, mainly in adults and elderly. The purpose of this study was 
to assess the relationship between health-related quality of life in patients with diabetes and sex, 
body mass index, type of diabetes and treatment regimens (type 1 diabetes: intensive versus 
conventional treatment; type 2 diabetes: insulin use versus non-insulin use), and duration of 
diabetes.
Methods: One hundred and twenty-four patients with diabetes were interviewed. Health-related 
quality of life was evaluated using the age-adjusted Short-Form 36 dimensions (physical function-
ing, role-physical, bodily pain, general health, vitality, social functioning, role-emotional, and 
mental health), and related to demographic and clinical variables. Independent samples t-tests 
and One-Way Analysis of Variance were used to compare means of independent samples. The 
degree of association between pairs of variables was measured by Pearson’s (r) or Spearman’s (r
s
) 
correlation coefficients.
Results: The mean age of the study population was 55.7±16.4 years; 54.8% were male, and 
77.4% had type 2 diabetes. Females reported worse quality of life than males in all dimensions of 
the Short-Form 36, except for role-physical and bodily pain. Obese patients had worse physical 
functioning than normal weight and overweight patients, and worse vitality than their normal 
weight counterparts. Type 2 diabetic patients taking insulin had lower physical functioning 
and vitality than those without insulin therapy. Longer duration of diabetes was associated 
with lower physical functioning, role-physical, general health, vitality, role-emotional, and 
mental health.
Conclusion: Being female, obese, having type 2 diabetes and taking insulin, and having a 
longer disease duration are characteristics associated with worse age-adjusted quality of life 
in patients with diabetes.
Keywords: clinical variables, demographic variables, diabetes mellitus, health-related quality 
of life
Introduction
According to the International Diabetes Federation, the worldwide prevalence of 
adults with diabetes mellitus (DM) is 8.3%, accounting for approximately 382  million 
people.1 In the People’s Republic of China, the prevalence of DM in adults aged 
20 years or older has increased to 9.7%, accounting for 92.4 million adults with DM.2 
With regard to the association between family history risk categories and prevalence 
of DM in Chinese adults aged 20 years or older and living in the People’s Republic of 
China, the prevalence has reached 32.7%, 20.1%, and 8.4%, representing at least two 
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generations and one generation of first-degree relatives with 
DM, and no first-degree relatives with DM, respectively.3
With the same tendency, the prevalence of type 2 DM 
has also increased sharply among Chinese immigrants in 
the USA, so a relevant and interesting conceptual model of 
type 2 DM self-management was designed and developed by 
a group of researchers from the People’s Republic of China 
and the USA for this specific group of individuals. This 
model has seven interrelated factors, ie, sociodemographic 
characteristics, behavioral and psychological characteristics, 
social support, linguistic barriers, cultural characteristics, 
type 2 DM self-management behaviors, and diabetes-related 
health outcomes (eg, health-related quality of life [HRQoL], 
HbA
1c
, blood pressure, and other cardiovascular risk factors), 
and postulates that the first five components have an influence 
on type 2 DM self-management, and that all factors except for 
the latter predict health outcomes.4 In Portugal, the prevalence 
of DM in people aged between 20 and 79 years has reached 
a worrying rate of 11.7%.5
HRQoL aggregates the individual’s subjective perception 
of physical, emotional, and social well-being,6–9 includes 
a cognitive and emotional component,9 and is becoming 
increasingly important for those providing health care for 
diabetic patients.10,11
Concerning the relationship between age, sex, body mass 
index (BMI), different treatment regimens of type 1 and 
type 2 patients, disease duration, and HRQoL in patients 
with DM, the studies have not been consistent, so it is 
important to evaluate the relationships between these fac-
tors and HRQoL.
To our knowledge, the research carried out in Portugal 
that evaluated the effect of certain demographic and clinical 
variables on HRQoL in patients with DM did not make the 
adjustment of HRQoL scores for age, despite the fact that 
they can mediate some of these relationships. Most studies 
have found that older age is related to worse HRQoL in DM 
patients.12–25 However, one study26 reported that older age of 
diabetic patients was related to better HRQoL, whereas Fal 
et al7 did not find a relationship between age and HRQoL. 
Other studies27–29 found that older age in diabetic patients was 
related to worse and better HRQoL in different dimensions. 
Diabetic males had better HRQoL12–14,16,21–24,29–32 than females. 
Nevertheless, some studies7,19,20,25,33 did not find any relation-
ship between sex and HRQoL in diabetic patients.
Concerning the relationship between BMI and HRQoL 
in DM, most of the studies have shown that patients with 
higher BMI had worse HRQoL.16,20,21,23,28,34,35 However, Mier 
et al36 did not find a relationship between BMI and HRQoL 
in type 2 diabetic patients. As far as we know, there are no 
studies conducted in Portugal that have evaluated the rela-
tionship between HRQoL and BMI in individuals with DM. 
According to two meta-analyses of randomized controlled 
trials that studied the effect of weight loss on HRQoL, posi-
tive clinical changes in BMI do not always produce a gain 
in HRQoL.37,38
With regard to the relationship between type of DM and 
HRQoL, some studies22,39,40 found that type 2 DM was related 
to worse HRQoL than type 1 DM, while other authors30,41 
found no relationship between type of DM and HRQoL. 
Trief et al27 found that type 2 DM was related to poor and 
better HRQoL in the different domains than type 1 DM. 
Another study33 found that patients with type 2 DM reported 
better HRQoL in one dimension of the Short-Form 36 than 
patients with type 1 DM, whereas in other dimensions of this 
generic tool assessing HRQoL, the two groups of patients 
did not differ.
Results of research on the relationship between treatment 
regimens in type 2 diabetic patients and HRQoL have found 
that insulin therapy was related to lower HRQoL.16,18,19,28,34,36,42 
Nevertheless, two studies17,26 reported an absence of a rela-
tionship between type of therapeutic regimen in type 2 DM 
and HRQoL, while two studies7,33 found that patients with 
type 2 diabetes treated with insulin had poor and better 
HRQoL in the different domains than those receiving oral 
hypoglycemic agents.
Concerning the relationship between treatment regimens 
in type 1 DM and HRQoL, one study22 found that type 1 
patients on a conventional insulin regimen reported worse 
HRQoL than those on an intensive insulin regimen. However, 
other study43 reported no relationship between treatment 
regimen in type 1 DM and HRQoL.
Finally, some studies looking at the relationship between 
duration of DM and HRQoL have shown that a longer dura-
tion of the disease was related to lower HRQoL;20,22,23,32,36 
however, others7,12,16,26,33 found no relationship between dia-
betes duration and HRQoL, and one43 found that an increased 
duration of DM was related to better HRQoL.
In summary, studies that have investigated the relationship 
between demographic and medical variables have used a wide 
range of methods6 and questionnaires44 to assess HRQoL, and 
have covered different aspects of HRQoL. These differences 
may contribute to the discrepancy between study results, and 
undermines the discussion of our present results.
Given the discrepancies found in the literature, and the 
lack of studies assessing HRQoL in Portuguese diabetic 
patients, the aim of this cross-sectional study was to assess 
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the relationship between HRQoL and age, sex, BMI, type of 
DM and treatment regimens, and duration of DM.
Subjects and methods
A consecutive sample of 124 patients from the Outpatient 
Department of Endocrinology, Diabetes and Metabolism, 
Centro Hospitalar São João, Porto, Portugal, was recruited. 
Patients were included in the study if they had a diagnosis of 
type 1 or type 2 DM, were at least 18 years old, and were not 
currently pregnant. The protocol for the study was approved 
by the Ethics Committee for Health at the Centro Hospitalar 
São João, and informed consent was obtained from all par-
ticipants before participation in the study.
BMI was calculated from participants’ self-reported 
heights and weights. BMI was expressed as weight (in 
kilograms) divided by the square of height (in meters), 
and categorized according to the World Health Organiza-
tion45 as “normal weight” (18.5–24.9 kg/m2), “overweight” 
(25–29.9 kg/m2), or “obesity” ($30 kg/m2). Treatment 
regimens for type 1 DM were classified as “conventional 
treatment” (one or two daily administrations of insulin) 
or “intensive treatment” (at least three daily administra-
tions of insulin). Type 2 DM patients were classified as on 
“oral hypoglycemic agents” or “insulin therapy” (the latter 
including patients only on insulin therapy or on oral hypo-
glycemic agents plus insulin therapy). Duration of DM was 
categorized as “less than 10 years”, “10–19 years”, or “20 
years or more”.
One questionnaire was designed to collect demographic 
and clinical data. General HRQoL was assessed by the 
Portuguese version of the Medical Outcomes Study 36-Item 
Short-Form Health Survey (SF-36).46,47 The eight domains 
used to assess HRQoL in this analysis were: physical func-
tioning, role-physical, bodily pain, general health, vitality, 
social functioning, role-emotional, and mental health. Raw 
dimension scores were transformed to scales ranging from 
0 to 100, in which higher scores indicate higher HRQoL. 
Given the relationship between age and HRQoL, we adjusted 
our SF-36 results to the age of the participants; therefore, all 
other variables were related to the residuals of simple linear 
regression models having each dimension as a dependent 
variable and age as the independent variable. All question-
naires were administered by one of the researchers.
Statistical Package for the Social Sciences version 20.0 
for Windows software (IBM Corporation, Armonk, NY, 
USA) was used for the analysis. Descriptive statistical 
analysis included calculation of means and standard devia-
tions for cardinal variables, and frequencies for ordinal and 
nominal variables. Independent samples t-tests and One-Way 
Analysis of Variance were used to compare means of inde-
pendent samples; when significant differences were observed 
using analysis of variance, we performed multiple compari-
sons for observed means using the Bonferroni correction. 
The degree of association between pairs of variables was 
measured by Pearson’s (r) or Spearman’s (r
s
) correlation 
coefficients. Chi-square tests were used to determine the 
dependency between pairs of variables. Relationships were 
considered to be statistically significant at P,0.05.
Results
Demographic and diabetes-related data are presented 
in Table 1. We interviewed 124 patients with DM aged 
18–80 years. Most patients were male, had type 2 DM, had had 
the disease for 10 years or more, and were overweight or 
obese. Table 2 summarizes the demographic and clinical char-
acteristics of the patients. Women had the longest duration of 
DM and a higher prevalence of obesity. Type 2 patients and 
overweight patients were older than the other patients.
The average values obtained by patients in the eight dimen-
sions of the SF-36 are shown in Table 3, as well the relation-
ship between these scores and age. There was an association 
between age and six of the eight dimensions of the SF-36: 
increased age was associated with worse HRQoL in terms of 
physical functioning, role-physical, bodily pain, vitality, social 
functioning, and role-emotional. Physical functioning was the 
dimension showing the strongest relationship with age.
Table 1 Demographic and clinical characteristics of patients
Sex
 Male n (%) 68 (54.8)
 Female n (%) 56 (45.2)
age (years)
 Whole sample, mean (SD) 55.7 (16.4)
 Type 1 DM, mean (SD) 32.8 (13.9)
 Type 2 DM, mean (SD) 62.4 (9.6)
Type of treatment regimens
 Type 1 DM conventional treatment n (%) 14 (11.3)
 Type 1 DM intensive treatment n (%) 14 (11.3)
 Type 2 DM without insulin therapy n (%) 50 (40.3)
 Type 2 DM on insulin therapy n (%) 46 (37.1)
Duration of DM (years)
 ,10, n (%) 47 (37.9)
 10–19, n (%) 39 (31.5)
 $20, n (%) 38 (30.6)
Body mass index category (kg/m2)
 18.5BMi,25.0, n (%) 34 (27.4)
 25.0BMi,30.0, n (%) 46 (37.1)
 BMi$30.0, n (%) 44 (35.5)
Abbreviations: DM, diabetes mellitus; SD, standard deviation.
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The age-adjusted scores of HRQoL by sex are shown in 
Table 4, BMI class in Table 5, and type of DM and treatment 
regimens in Table 6.
Diabetic women had worse HRQoL in terms of physi-
cal functioning, general health, vitality, social functioning, 
role-emotional, and mental health than men, and evidenced 
a tendency in the same direction in terms of role-physical 
and bodily pain.
Obese patients had lower HRQoL in terms of physical func-
tioning when compared with normal and overweight patients, 
and reported worse vitality than normal weight patients.
Type 2 patients on insulin therapy had worse physical 
functioning and vitality than type 2 patients only on oral 
hypoglycemic agents. Globally, type 2 patients taking 
insulin tended to show poorer HRQoL than patients in 
other  treatment regimens, except in terms of role-physical. 
Intensively treated type 1 patients tended to have better 
HRQoL than patients on other treatment regimens, except 
in terms of social functioning and role-emotional.
An increased duration of DM (measured according to 
the categories presented in Table 1) was associated with 
lower HRQoL in terms of physical functioning (r
s
 =−0.271, 
P=0.002), role-physical (r
s
 =−0.209, P=0.020), general health 
(r
s
 =−0.372, P,0.001), vitality (r
s
 =−0.312, P,0.001), 
role-emotional (r
s
 =−0.224, P=0.012), and mental health 
(r
s
 =−0.197, P=0.028). In terms of social functioning, there 
was a tendency in the same direction; however, it did not reach 
statistical significance (r
s
 =−0.160, P=0.077).  Regarding 
bodily pain dimension, it seemed to exist no relationship 
with duration of disease (r
s
 =−0.045, P=0.621).
Table 2 relationships between demographic and clinical characteristics of patients
Sex Age
Male Female P-value Mean (SD) P-value
n (% within sex) n (% within sex)
Type of treatment regimens
 Type 1 DM conventional treatment (n=14) 7 (10.3) 7 (12.5) 0.070 39.5 (14.9)a* ,0.001
 Type 1 DM intensive treatment (n=14) 8 (11.8) 6 (10.7) 26.1 (9.0)b*
 Type 2 DM without insulin therapy (n=50) 34 (50.0) 16 (28.6) 62.2 (9.8)c*
 Type 2 DM on insulin therapy (n=46) 19 (27.9) 27 (48.2) 62.7 (9.5)c*
Duration of DM (years)
 ,10 (n=47) 34 (50.0) 13 (23.2) 0.009 56.3 (16.3) 0.251
 10–19 (n=39) 18 (26.5) 21 (37.5) 52.4 (17.4)
 $20 (n=38) 16 (23.5) 22 (39.3) 58.5 (15.2)
Body mass index (kg/m2)
 18.5BMi,25.0 (n=34) 19 (27.9) 15 (26.8) 0.013 43.8 (20.7)a* ,0.001
 25.0BMi,30.0 (n=46) 32 (47.1) 14 (25.0) 60.7 (12.2)b*
 BMi$30.0 (n=44) 17 (25.0) 27 (48.2) 59.8 (11.4)b*
Note: *Presence of the same letter (a,b,c) in superscript indicates absence of significant differences in post hoc tests. 
Abbreviations: DM, diabetes mellitus; SD, standard deviation.
Table 3 health-related quality of life in patients with DM and its 
association with age
SF-36  
dimensions
Percent Association 
with age
Mean (SD) r (P-value)
Physical functioning 41.9 (37.1) −0.536 (,0.001)
role-physical 39.3 (48.6) −0.286 (0.001)
Bodily pain 45.1 (33.8) −0.312 (,0.001)
general health 46.6 (17.5) −0.150 (0.097)
Vitality 46.0 (26.6) −0.199 (0.027)
Social functioning 57.4 (28.2) −0.270 (0.002)
role-emotional 61.8 (48.0) −0.269 (0.003)
Mental health 51.9 (24.5) −0.146 (0.105)
Note: r, Pearson’s correlation coefficient. 
Abbreviations: DM, diabetes mellitus; SF-36, Medical Outcomes Study 36-item 
Short-Form health Survey; SD, standard deviation.
Table 4 health-related quality of life in patients with diabetes 
mellitus and their sex
SF-36 dimensions 
(adjusted for age)
Sex
Male Female P-value
Mean (SD) Mean (SD)
Physical functioning 11.2 (33.7) −13.6 (21.6) ,0.001
role-physical 6.9 (47.2) −8.4 (44.8) 0.067
Bodily pain 5.0 (31.9) −6.1 (31.6) 0.054
general health 3.2 (15.5) −3.9 (18.6) 0.022
Vitality 6.5 (28.1) −7.9 (21.0) 0.001
Social functioning 7.2 (25.2) −8.7 (27.1) ,0.001
role-emotional 14.1 (43.0) −17.2 (44.6) ,0.001
Mental health 5.8 (23.5) −7.0 (23.3) 0.003
Abbreviations: SF-36, Medical Outcomes Study 36-item Short-Form health 
Survey; SD, standard deviation.
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SF-36 with the exception of the general health dimension; 
in physical functioning, bodily pain, vitality, and mental 
health of SF-36; and in all dimensions of the aforementioned 
instrument. Conversely, some studies7,19,20,25,33 found no rela-
tionship between sex and HRQoL. Different explanations for 
the worse HRQoL of women with DM have been presented: 
females have an increased risk of developing cardiovascular 
disease,48 being hypertensive, obese, having more symptoms 
related to hyperglycemia,49 presenting higher prevalence rates 
of depression,31,50 anxiety, having less energy,31 and presenting 
greater difficulty in doing physical exercise,50 and this factor 
may lead to worse HRQoL, particularly in some dimensions. 
An alternative explanation may be the fact that women find 
themselves overburdened with several competing demands, 
such as their commitments toward their closest relatives, 
as well as with their jobs and household activities, whereas 
men are more concentrated in their paid jobs, which may 
contribute to greater physical and psychological overload.51 
These above-mentioned sex patterns with regard to work roles 
were observed across countries. It is worth noticing that in 
Table 5 health-related quality of life in patients with diabetes mellitus and body mass index
SF-36 dimensions 
(adjusted for age)
Body mass index category (kg/m2)
18.5BMI,25.0 25.0BMI,30.0 BMI$30.0 P-value
Mean (SD) Mean (SD) Mean (SD)
Physical  
functioning
7.9 (29.3)a* 8.0 (34.9)a* −14.4 (23.4)b* ,0.001
role-physical 1.6 (50.0) −6.9 (42.1) −1.8 (47.6) 0.203
Bodily pain 3.6 (29.5) 1.3 (33.7) −4.2 (32.6) 0.540
general health 1.1 (14.9) 0.9 (17.6) −1.8 (18.8) 0.703
Vitality 6.9 (26.1)a* 2.3 (25.4)a,b* −7.8 (25.3)b* 0.034
Social functioning 2.9 (30.1) 3.6 (26.2) −6.1 (25.2) 0.182
role-emotional 6.3 (39.1) 2.2 (48.2) −7.2 (49.3) 0.414
Mental health 6.9 (21.2) −3.4 (22.9) −1.8 (27.0) 0.143
Note: *Presence of the same letter (a,b) in superscript indicates absence of significant differences in post hoc tests. 
Abbreviations: SF-36, Medical Outcomes Study 36-item Short-Form health Survey; SD, standard deviation.
Table 6 health-related quality of life and type of diabetes mellitus and treatment regimens
SF-36 dimensions 
(adjusted for age)
Type 1 diabetes mellitus Type 2 diabetes mellitus P-value
Conventional Intensive Without insulin With insulin
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Physical functioning 1.0 (36.4)a,b* 10.4 (14.9)a,b* 7.2 (34.2)a* −11.3 (27.3)b* 0.016
role-physical −10.2 (56.0) 12.3 (39.4) 8.2 (48.2) −9.5 (42.4) 0.163
Bodily pain 4.8 (33.3) 15.1 (20.0) −1.8 (33.9) −4.1 (32.1) 0.231
general health −1.7 (18.1) 8.4 (13.6) 1.7 (17.6) −4.0 (17.0) 0.093
Vitality −0.5 (28.7)a,b* 9.4 (23.3)a,b* 6.2 (26.2)a* −9.4 (23.6)b* 0.012
Social functioning 7.4 (31.1) 7.4 (23.7) 1.4 (25.8) −6.0 (27.9) 0.214
role-emotional 11.1 (37.5) 2.9 (28.6) 4.6 (48.1) −9.2 (50.3) 0.367
Mental health 4.8 (27.6) 8.2 (17.9) 0.6 (23.7) −4.6 (25.1) 0.282
Note: *Presence of the same letter (a,b) in superscript indicates absence of significant differences in post hoc tests. 
Abbreviations: SF-36, Medical Outcomes Study 36-item Short-Form health Survey; SD, standard deviation.
Discussion
Demographic and clinical variables in patients with DM were 
related to HRQoL, regardless of age. Globally, we highlight 
physical functioning and vitality as the dimensions more 
related to these variables. The adjustment of SF-36 scores 
for age may obscure relationships between several clinical 
variables and HRQoL dimensions that strongly depend on a 
concomitant relationship with age. Therefore, absolute scores 
on the SF-36 and their relationship with clinical variables 
may have clinical usefulness, but to analyze their direct effect 
on HRQoL, which was our intention, it is recommended that 
values are adjusted for age.
Our results showed that being female was related to 
worse HRQoL in terms of physical functioning, general 
health, vitality, social functioning, role-emotional, and men-
tal health, and a tendency in the same direction in terms of 
role-physical and bodily pain. These findings are partially 
in agreement with those of Kleefstra et al, Neves et al, and 
Papadopoulos et al,21–23 who found that diabetic females 
reported, respectively: lower HRQoL in all dimensions of 
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our study women showed the longest duration of DM and 
a higher prevalence of obesity, which may act as confound-
ers contributing to the worse HRQoL. On the other hand, 
the relationships between age and some clinical variables, 
namely the type of DM and BMI, highlight the relevance of 
age-adjustment to the HRQoL scores.
Although Mier et al36 reported no relationship between 
obesity in type 2 DM and HRQoL, we found that obese 
patients assessed their HRQoL as being worse than normal 
and overweight individuals in terms of physical functioning. 
It was previously shown that an increasing BMI in type 2 
DM was related to lower physical functioning,20,21,23,34 as 
well as in worse HRQoL in other dimensions of the SF-36: 
role-physical,20,21 bodily pain,21 general health,34 social 
functioning,21,34 and role-emotional.20 We also emphasize that 
obese patients had lower vitality than their normal weight 
counterparts. However, as far as we know, we found no study 
reporting that obese diabetic patients had worse HRQoL 
in this particular dimension in comparison with normal 
and overweight ones. A possible explanation for the worse 
physical functioning and vitality in obese patients may be 
related to the coexistence of hypertension or other chronic 
morbidities in this group of patients.
While Wexler et al and Caldwell et al17,26 did not observe 
any relationship between treatment regimens in type 2 DM 
and HRQoL, we observed that insulin therapy in type 2 
DM was related to lower scores on the physical functioning 
dimension compared with those who were on oral hypogly-
cemic agents, in accordance with previous research.18,19,34 
 Moreover, Johnson et al19 reported that insulin use in type 2 
DM was related to worse HRQoL in terms of role-physical, 
general health, and social functioning. Interestingly, Fal et al7 
observed that patients with type 2 diabetes on insulin therapy 
had worse HRQoL in the somatic and environmental domains 
and better HRQoL in the psychological domain than those 
receiving oral hypoglycemic agents. Additionally, we found 
that type 2 diabetic patients treated with insulin showed 
poorer vitality than type 2 patients not treated with insulin 
therapy. Nevertheless, to our knowledge, there are no studies 
reporting that insulin use is related to worse HRQoL for this 
specific dimension in type 2 diabetic patients.  Different expla-
nations have been put forward by various authors to explain 
the lower HRQoL in patients requiring insulin to achieve bet-
ter metabolic control: the side effects of the medication and its 
influence on scheduling and organizing their daily activities,7 
the fear of weight gain, and concerns about the impact of the 
insulin regimen on their social environment.52 Alternative 
explanations for these findings in such patients may be the 
longer duration of the disease, a sense of frustration after 
failure of oral medications, or the onset of diabetes-related 
complications and subsequent necessity to start insulin. 
Patients commonly held erroneous and irrational beliefs 
about the relationship of the need of insulin therapy and the 
development of chronic complications of DM. Subcutane-
ous insulin injection is also often considered as an intrusive 
regimen by patients. These hypotheses should be tested in 
future research, on the one hand using larger samples allow-
ing multivariate analysis, and on the other hand by qualitative 
studies focusing on the personal representations of different 
features of treatment regimens.
In our study, there were no differences on any of the 
HRQoL dimensions between type 1 patients on a conven-
tional regimen and those on an intensive insulin regimen, 
which is consistent with the results obtained by Eiser et al43 
but different from the findings of Neves et al,22 who found 
better HRQoL in terms of physical functioning and vitality 
in type 1 patients on an intensive insulin regimen. Eventually, 
the absence of differences in terms of HRQoL between insu-
lin treatment regimens in type 1 DM may be related to the 
small number of patients interviewed.
Some studies did not find a relationship between duration 
of diabetes and HRQoL in type 2 DM7,12,16,26,33 or in type 1 
DM,33 and another study43 reported better HRQoL in terms 
of diabetes satisfaction with increasing duration of the 
disease in young adults with type 1 DM. In contrast, across 
both type 1 and type 2 patient groups, we found a negative 
association between duration of diabetes and HRQoL in 
terms of physical functioning, role-physical, general health, 
vitality, role-emotional and mental health, and a tendency 
in the same direction in terms of social functioning. These 
results, on one hand, are partially overlapping with the find-
ings of Neves et al,22 since in that study an increased duration 
of DM was related to lower HRQoL in all dimensions of the 
SF-36, but on the other hand partially agree with the find-
ings of Kalda et al, Papadopoulos et al, and Mier et al,20,23,36 
who found that a longer duration of diabetes was related to 
worse general health, vitality, social functioning,20,23 bodily 
pain,23 mental health,20 and physical component.36 Possible 
explanations for this reduction in HRQoL for diabetic 
patients with a longer duration of disease may be related to 
the sharp decrease of energy, vitality, and social relation-
ships, the development of long-term complications of DM 
in the later stages of the disease, and consequently to the 
intensification and complexity of the treatment regimen.20 It 
is worth noticing that, by comparing age-adjusted HRQoL 
scores, the relationship found between duration of diabetes 
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and HRQoL is not due to the older age of patients, but to 
the longer duration of DM.
The difference in the results between this study and others 
may be explained, on the one hand, by the different generic 
tools used to assess HRQoL, which do not measure exactly 
the same dimensions, and by the fact that some studies have 
evaluated only type 1 or type 2 diabetic patients, whereas in 
the present study both types of patients were included. Given 
the frequent age difference between patients with type 1 
diabetes and those with type 2 diabetes, and due to the fact 
that not all studies make the age-adjustment of the values of 
the generic instruments to assess HRQoL for this variable, we 
highlight the implications for clinical practice when HRQoL 
is evaluated considering age-adjusted values.
Several limitations of this study should be considered 
when interpreting its results. The results would be more 
robust with a larger sample. Further, most of the patients 
interviewed were of low sociocultural status, which may have 
limited their understanding of the questions in the instrument 
used to assess HRQoL. Generalization of our findings may 
be limited because our sample was collected in a central 
public hospital and might not be representative of the diabetic 
population in other care centers or in primary care. Further 
investigations are warranted to adjust the dimensions of 
HRQoL to other variables (eg, sex, BMI, type of DM and 
treatment regimens, and disease duration) to explore the 
relationships between HRQoL and the demographic and 
clinical variables considered, we think may explain some of 
these relationships. Further studies are needed to explore the 
relationships between demographic and clinical variables. As 
previously stated, the use of qualitative methodology could be 
useful to obtain information complementary to that achieved 
by quantitative studies, allowing more accurate interpretation 
of some results. Finally, participants’ self-reported duration 
of diabetes, and height and weight values when calculating 
BMI might not be as reliable as measurements taken from 
official medical records.
One of the main points of our results is the relationship 
found between the vitality dimension of the SF-36 and obe-
sity and insulin use in patients with type 2 DM. To our knowl-
edge, there are no studies providing such data (ie, reporting 
the negative impact of these two factors on this specific 
dimension of HRQoL), which seems worthy of exploring 
further. Apart from the reasons previously stated, adjusting 
HRQoL values for age is important, since type 1 patients are 
significantly younger than those with type 2 diabetes, and 
our analysis allowed us to analyze and compare these two 
groups without the confounding effect of age.
Conclusion
Our findings suggest that being female, obese, having type 2 
DM and taking insulin, and having diabetes for a longer 
period of time are characteristics associated with worse age-
adjusted HRQoL in patients with DM. Globally, physical 
functioning and vitality were the dimensions more related to 
these demographic and clinical variables.
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